Parasite epigenetics and immune evasion: lessons from budding yeast
© Wyse et al.; licensee BioMed Central Ltd. 2013
Received: 30 August 2013
Accepted: 11 November 2013
Published: 19 November 2013
Skip to main content
© Wyse et al.; licensee BioMed Central Ltd. 2013
Received: 30 August 2013
Accepted: 11 November 2013
Published: 19 November 2013
The remarkable ability of many parasites to evade host immunity is the key to their success and pervasiveness. The immune evasion is directly linked to the silencing of the members of extended families of genes that encode for major parasite antigens. At any time only one of these genes is active. Infrequent switches to other members of the gene family help the parasites elude the immune system and cause prolonged maladies. For most pathogens, the detailed mechanisms of gene silencing and switching are poorly understood. On the other hand, studies in the budding yeast Saccharomyces cerevisiae have revealed similar mechanisms of gene repression and switching and have provided significant insights into the molecular basis of these phenomena. This information is becoming increasingly relevant to the genetics of the parasites. Here we summarize recent advances in parasite epigenetics and emphasize the similarities between S. cerevisiae and pathogens such as Plasmodium, Trypanosoma, Candida, and Pneumocystis. We also outline current challenges in the control and the treatment of the diseases caused by these parasites and link them to epigenetics and the wealth of knowledge acquired from budding yeast.
Varying genes and known mechanisms of variation in different pathogens
Varying genes (number of genes given in parentheses)
Mechanisms involved in gene variation
Epigenetic switches, DNA recombination
VAR (60), rifin (150 to 200), and stevor (30 to 35)
Various subtelomeric genes
Mating type loci (HMR α and HMLα)
Trypanosomes are bloodstream parasites with a most remarkable ability to evade the immune system and to cause severe diseases such as nagana (Trypanosoma vivax, T. congolense) and sleeping sickness (T. brucei) . These maladies are characterized by extreme fatigue and sleepiness. T. brucei is the prevalent pathogen in humans and has become a prototype for antigenic variation. It harbors a massive family of more than 1,000 mostly subtelomeric variant surface glycoprotein (VSG) genes and pseudogenes.
The only active VSG in T. brucei is expressed from one of 15 dedicated expression sites, while the active MSG in P. carinii is expressed from one unique expression site [4, 5] (Figure 1A,B). These expression sites are adjacent to a telomere and contain gene promoters plus other regulatory elements. The pools of silent intact VSG and MSG genes plus pseudogenes and other VSG and MSG homologous sequences serve as a depot of donor elements that are translocated to the expression sites via DNA recombination [5, 20] (Figure 1A,B). It is not known how the frequency of these recombination events is controlled . However, it seems apparent that the silencing of the VSGs in T. brucei is accomplished by epigenetic means [21, 22]. Strong support for this idea is offered by the observations that the knockdowns of key heterochromatin regulators (SIR2, RAP1, DOT1A) leads to their derepression [21, 23, 24]. No genetic evidence is available from Pneumocystis. It is noteworthy that a similar constitutive repression of ‘donor’ genes and their translocation to an active site governs the switching of the mating type in S. cerevisiae. These parallels are extensively covered [3–5] and will not be reviewed here.
Of the 15 VSG expression sites in T. brucei, only one is active at a time. Early during the infection, the VSG switching is conducted mostly by rapid epigenetic on-off transitions between these expression sites (Figure 1B). Later on, the switching involves both epigenetic and DNA recombination events [3, 4]. It is not known how the expression from a single site is achieved.
Different species of Plasmodium cause malaria by invading red blood cells in a wide variety of organisms. The pathogens undergo a complex life cycle that involves transmission by mosquitoes and a latency period in the livers of the hosts [7, 8]. P. falciparum, one of the most extensively studied malaria pathogens, is chosen as a paradigm for gene variation by epigenetic switches. During blood-stage infection this pathogen expresses alternative forms of the immunodominant antigen P. falciparum erythrocyte membrane protein 1 (PfEMP1). The expressed PfEMP1 is trafficked by specialized vesicular structures and then displayed on the surface of the infected erythrocytes . Using PfEMP1 as an adherent, the infected erythrocyte is sequestered to the vascular walls to contribute to the severe symptoms of malaria. PfEMP1 is encoded by a limited family of 60 VAR genes, which are positioned in the subtelomeric regions of the chromosomes and in several interchromosomal clusters. An elaborate and poorly understood mechanism of coordinated silencing of the VAR genes is combined with rare epigenetic switches to other variants to confer an ever-shifting antigenic makeup (Figure 1C). This strategy is sufficient to minimize recognition of PfEMP1 by the immune response  and, at the same time, prevents the exhaustion of the reservoir of VAR genes [25–27]. Other families of surface proteins (rifin, stevor, PfMC-2TM) also contribute to antigenic variation, but PfEMP1 is believed to be the critical driving force of the immune evasion [7, 9]. Besides epigenetic switches, there is solid evidence for frequent gene conversions between VAR genes . While these contribute to the diversification of the gene family, such events do not directly contribute to the switching of the PfEMP1 surface antigens.
The coordinated silencing of all but one VAR gene is the crux of prolonged malaria infections and the slowly developing and incomplete immunity to the pathogen. Consequently, the factors that contribute to antigenic variation in P. falciparum have been extensively studied [7, 9, 25, 28]. While a significant body of information has been acquired, the mechanisms of VAR silencing remain unknown [9, 26, 27, 29–31]. For example, it is not clear what kind of cis-elements serve as VAR silencers. The introns  and a conserved region upstream of the VAR promoters [30, 33, 34] have been proposed to act as silencing elements, but later on the significance of the intron has been debated [7, 30]. The pairing of VAR genes has also been proposed to contribute to repression, but the mechanistic details are yet to be elucidated [30, 34]. However, it has been conclusively shown that histone acetylation, histone methylation, and the propagation of heterochromatin away from the telomeres control the VAR genes [35–39]. Another line of evidence suggests that the tethering of VAR genes to poorly characterized subdomains in the nuclear periphery could be critical for both their repression and switching [31, 40, 41]. In addition, there is widespread expression of long non-coding RNAs in blood-stage P. falciparum[42–45], but no conclusive evidence for the regulation of VAR genes by such RNAs has been obtained [46–48].
Candida glabrata is an opportunistic parasite that causes prolonged urinal tract infections . The key event in these infections is the adhesion of C. glabrata to host epithelial cells via epithelial adhesin (EPA) genes. Antigenic variation in this species is conferred by 23 EPA genes, which are positioned in the subtelomeric regions (Figure 1D) and are repressed by the NADH-dependent histone deacetylase SIR2[49, 50]. Interestingly, C. glabrata is a nicotinic acid auxotroph. It is believed that the repression of EPA genes relies on the NADH provided by the host. Once the parasite moves to the urinary tract (there is very little nicotinic acid in the urine) the activity of Sir2p diminishes and the EPAs, and EPA1 in particular, are expressed [2, 11].
Giardia lamblia is a human intestinal pathogen that causes mild to severe diarrhea. Infection is transmitted by ingestion of cysts followed by the attachment of Giardia to the intestinal cells via variant-specific surface protein (VSP) genes. G. lamblia displays distinctive antigen variation through changes in the expression of about 220 VSP genes . However, there are notable distinctions in the control of variation between Giardia and the previously described species. First, VSP genes are not clustered in the subtelomeric regions. Second, it has been suggested that multiple VSP genes are expressed and then all but one of the VSP mRNAs are repressed by an elaborate endogenous RNAi system that remains to be fully characterized [12–14]. No DNA methylation has been demonstrated in this organism .
Unlike many higher eukaryotes, DNA methylation plays no role in the repression of subtelomeric genes in S. cerevisiae. In addition, while long non-coding RNA (called telomeric repeat-containing RNA, TERRA) is produced by the yeast subtelomeric DNA, a role of this RNA in gene silencing and switching has not been established . These peculiarities have rendered this model organism somewhat irrelevant to epigenetics in higher eukaryotes. However, they make it quite relevant to the parasites that were discussed earlier. While budding yeasts cannot represent the whole variety of mechanisms for antigenic variation, some noteworthy similarities do exist. In Plasmodium, Candida, Trypanosoma, and Pneumocystis, the gene families that contribute to antigenic variation are mostly or exclusively located in the subtelomeric regions of the chromosomes. The repression of these subtelomeric genes is highly dependent on histone modifications [23, 24, 39, 49, 51, 56–58], whereas in other eukaryotes the formation and maintenance of heterochromatin is more complex and involves additional levels of regulation. For example, similarly to S. cerevisiae and in contrast to higher eukaryotes, DNA methylation and RNAi do not seem to contribute to the silencing of the variance genes [7, 15].
In S. cerevisiae and P. falciparum the silenced variation loci cluster in the nuclear periphery [8, 15, 59]. In S. cerevisiae, the relocation of these loci leads to derepression . In P. falciparum, relocation to another ‘active’ domain, still in the nuclear periphery, is believed to contribute to the switching and the activation of VAR genes [7, 33].
In S. cerevisiae, P. falciparum, and possibly other pathogens, the epigenetic silencing of genes needs a passage through the S phase [32, 53], but it is not clear if DNA replication itself is the required process .
In order to implement antigenic variation, the parasites must execute three distinct tasks. First, they need to selectively and exclusively activate one gene of the family at a time. Second, they need to effectively repress all but one of the genes of the family. Third, they need to switch the active gene at a frequency that runs ahead of the building immune response but does not exhaust the repertoire of the gene family.
The key question, how to selectively express one and only one gene of the extended family, remains unanswered. Ostensibly, the means must be coupled to the repression of all other genes, but how a gene is singled out is a persisting mystery. A common theme in the studies in Pneumocystis and Trypanosoma is the existence of expression sites [3, 7]. In Pneumocystis the single expression site determines the expressed variant. This situation calls for regulated DNA recombination events at a frequency that will not jeopardize the pool of MSG genes. The same applies to the VSG genes in trypanosomes except that the situation there is complicated by the multiplicity of expression sites and their exchange through bona fide epigenetic means. A clue from S. cerevisiae suggests that the expressed site in trypanosomes could be related to the position of the active locus in the nucleus. In S. cerevisiae the telomeres cluster in several compartments in the nuclear periphery. Upon translocation to the nucleoplasm the telomeric genes lose repression . A few proteins, including the Ku antigen and the nuclear pore components, contribute to this peripheral clustering [59, 61]. A similar clustering of the inactive VAR genes in the nuclear periphery is apparent in Plasmodium, but the active VAR gene remains in the nuclear periphery slightly away from the repressed cluster [7, 8]. These observations are consistent with the idea that the sub-nuclear localization of the VAR or VSG loci is linked to the expression of these genes. However, it is not clear if this differential localization is the cause or the consequence of the switch from silenced to active state.
Another clue from budding yeasts points to the fine architecture of subtelomeric DNA as combined with the balance of transcriptional activators and repressors. In S. cerevisiae, subtelomeric DNA consists of conserved core X and Y’ elements and harbors degenerate internal telomeric repeats (ITS), silent origins of DNA replication (ACS), and isolated binding sites for Rap1p (Figure 2B). These act as protosilencers and relay the spreading of SIR proteins away from the chromosome ends (Figure 2D) . Additional complexity is provided by subtelomeric anti-silencing regions (STARs) and chromatin boundaries (Figure 2C) [63–65]. Likewise, the folding of the telomere and the establishment of t-loops and G-quadruplexes also contributes to complexity [63, 66, 67]. In this vein, G-quadruplex structures have been recently characterized in P. falciparum, while protosilencers have been conclusively identified in C. glabrata[69, 70]. The SPE sites and the subtelomeric TARE3 in P. falciparum (Figure 1C) have also displayed properties consistent with protosilencing or boundary activities [45, 71]. It is therefore tempting to speculate that assemblies of cis-elements similar to these in S. cerevisiae also exist in parasites.
It has been shown that in S. cerevisiae, the protosilencers, STARs, and chromatin boundaries can confer isolated expression of a gene imbedded in a heterochromatic region (Figure 2D) [64, 66]. At the same time, studies in S. cerevisiae and D. melanogaster have shown that the abundance/strength of transcriptional activators counteract the silencing of target genes [72–74]. In S. cerevisiae, it has been demonstrated that overexpression of the trans-activator Ppr1p antagonizes the silencing of a telomeric URA3 reporter and that progression through S phase was necessary for the establishment of the active state . It is conceivable that in parasites a similar mechanism of silent to active transition could exist. For example, an increase of variance gene-specific transcriptional activators and/or STAR binding factors accompanied by a passage through S phase could destabilize the repression of all genes in the family and predispose them to a conversion (see model in Additional file 1). Although the currently expressed gene has the advantage to remain active through epigenetic heritance , another gene could compete via the engagement of the chromatin boundaries and the gradual sequestration of limiting gene-specific activators. Reversion to a lower abundance of such activators would reinstate the robust repression of the other variance genes and uphold the conversion. Hence, the interplay between weak cis-elements and subtle changes in the abundance of transcription factors could significantly contribute to the elusive mechanism of epigenetic switches. In support, such temporary destabilization and expression of multiple VAR genes before a single VAR gene is selected has already been observed in P. falciparum[30, 31, 75]. Interestingly, there was an increase in the rate of switching at subtelomeric VAR loci as compared to switching at the internal loci. By all means, a closer look at the subtelomeric DNA of these parasites and a search for protosilencers, boundary, and/or anti-silencing elements and factors is warranted.
Lessons from budding yeasts have provided a basic framework for the understanding of this process in parasites. The central mechanism of the spreading of deacetylation from the telomeres operates in these and many other eukaryotes (Figure 2A) [15, 52]; however, some exceptions need to be mentioned. As in budding yeast, Sir2p is a critical factor for the silencing of the varying genes in P. falciparum and C. glabrata, but it is not essential for the VSGs in T. brucei and its role in P. carinii is unknown [11, 35, 40, 49, 56–58, 76]. Similarly, the telomere-binding protein Rap1 is essential for telomeric silencing in T. brucei and C. glabrata, but no evidence for its role in Plasmodium or Pneumocystis is available. Another feature that appears conserved between parasites and yeasts is the existence of histone variants that are specific to silent and active chromatin. In S. cerevisiae, H2A.Z antagonizes telomeric silencing and is enriched at chromatin boundaries . A similar but more complex exchange of histones functions in P. falciparum where the unusual H2A.Z/H2B.Z double-variant nucleosomes are prevalent at active genes, but are excluded from silenced VAR genes . Histone variants have also been described in T. brucei, but their relevance to gene silencing, if any, is not clear [79, 80].
The methylation of histones poses even greater uncertainty. Methylation at specific K/R residues is associated with both gene activation and gene repression and is catalyzed by two classes of histone methyltransferases, SET and DOT1 . In S. cerevisiae, the trimethylation of H3K79 by Dot1p has long been considered a key event in telomeric silencing , while the methylation of H3K36 by Set2p has been continuously linked to active transcription . It was surprising to learn that the methylation of H3K36 by P. falciparum variant-silencing SET (PfSETvs) was critical for the repression of VAR genes in P. falciparum. In T. brucei, the deletion of DOT1B does not lead to a general derepression, but increases the duration of the epigenetic switch . In summary, although histone methylation at specific residues certainly contributes to gene silencing, significant variations between different parasites and S. cerevisiae could be expected.
Where does this notion lead us? It is feasible that the disruption of histone acetylation and methylation will preclude gene silencing and will cause the expression of many if not all of the varying genes. Indeed, it has been shown that the deletion of the homologues of SIR2, DOT1, or SET2 can produce pathogens that display multiple antigens [24, 39, 58]. These mutants, when properly attenuated, can be used for the successful generation of vaccines. Currently, the lack of vaccines is one of the most haunting issues in malaria and sleeping sickness [7, 39, 83–85]. In this respect, the gained knowledge of gene silencing can deliver a major breakthrough in the prevention of these devastating maladies. It is also conceivable that the drug targeting of the parasite homologues of the Sir2, Rap1, Set2, or Dot1 proteins can be used to combat the infections. To date, inhibitors of histone deacetylases or methyltransferases have shown promise under laboratory conditions [38, 86]. However, this approach certainly needs fine-tuning. Because the varying surface antigens are directly linked to morbidity, their potential overexpression could produce ‘super-pathogens’ in the patients and will offset any gain in immunity. The risk of such a possibility has been demonstrated in vitro in C. glabrata.
An alternative to the risky and harmful overexpression of surface antigens is the reduction in the frequency of epigenetic switches. The rationale is that the immune system would gain ample opportunity to combat and clear the parasite. Unfortunately, the actual mechanisms of epigenetic conversions in S. cerevisiae or in the pathogens are not known . While many regulators of TPE have been identified, the majority of them expand or contract the subtelomeric heterochromatin domain [15, 88]. Hence, they do not necessarily alter the frequency of switching. Mutations in other regulators produce higher levels of the expression of otherwise silenced reporters [89, 90], but it is hard to tell if modest loss of repression or frequent epigenetic conversions have yielded these results.
A decrease in the rate of switching is a reliable criterion for true deregulation, but it is rarely observed. To our knowledge, only one study in parasites (T. brucei) has shown such an effect. As mentioned above, in this species the deletion of DOT1B retards the epigenetic switch to a point where the cells express two VSGs for weeks . Interestingly, in S. cerevisiae the trimethylation of H3K79 (it is catalyzed by Dot1p), but not DOT1 itself, increases the rate of the silencing establishment . Five other studies in S. cerevisiae have reported the so-called ‘enhanced memory for heritable transmission’. Two of them have characterized mutations in histone H4, which increase the stability of both the repressed and the active states of subtelomeric reporters [92, 93]. Two other papers [94, 95] have pointed out that SIR1 alters the frequency of conversion at the mating type loci. Sir1p binds to dormant origins of DNA replication (these act as silencers of the mating loci) and recruits Sir2p . Recently, we reported that the deletion of CAC1 reduces the frequency of epigenetic conversions of subtelomeric reporters . Cac1p is a component of chromatin assembly factor I (CAF-I), which travels along with the replication forks and reassembles H3/H4 into nucleosomes on newly synthesized DNA . It seems that both local silencers and the passage of replication forks act to occasionally change the epigenetic state of genes.
It is of particular interest that a replication fork factor contributes to epigenetic conversions. It is well known that the passage of the fork disperses the existing nucleosomes . The subsequent reassembly combined with subtle variations in the abundance of variant gene-specific factors could both bestow the opportunity for a switch, as depicted in Additional file 1. This notion is in tune with the observations in S. cerevisiae and P. falciparum that the establishment of silencing requires a passage through S phase [7, 52]. In a similar vein, a recent study in P. falciparum has demonstrated that the repositioning of a gene (P. falciparum reticulocyte binding protein-like homologue 4, PfRh4) to an active site in the nuclear periphery is associated with more frequent active to silent epigenetic switching . It is attractive to speculate that these conversions are promoted by the open chromatin environment and that both replication forks and the state of existing nucleosomes determine the frequency of epigenetic switches. At present, CAF-I is the only candidate that could potentially confer reduced switching and non-varying phenotype in the parasites. However, other histone chaperones such as the homologues of the yeast ASF1, Rtt106, FACT, or HST should be considered. The exploration of this possibility may generate new drug targets and a truly new class of anti-pathogen drugs.
Parasites like Plasmodium and Trypanosoma cause devastating maladies in millions of people and are a leading cause of death in many developing countries. Others such as Pneumocystis could be deadly opportunistic agents. They all share a common powerful weapon: antigenic variation. The remote yeast S. cerevisiae has provided a paradigm and a framework to study positional effects, which are very relevant to the underlying mechanisms of antigenic variation. In the opinion of the authors, researchers need to turn more often to yeasts for clues on how to disarm such pathogens.
ARS consensus sequence
Autonomously replicating sequence
Chromatin assembly factor I
Disruptor of telomeric silencing 1
Expression site-associated gene
Internal telomeric sequences
Major surface glycoprotein
Origin recognition complex
P. falciparum erythrocyte membrane protein 1
P. falciparum reticulocyte binding protein-like homologue 4
P. falciparum variant-silencing SET
P. falciparum SPE2 interacting protein 2
Repressor activator protein-1
Silent information regulator
Subtelomeric anti-silencing region
Telomere-associated repeat element
Telomeric repeat-containing RNA
Telomere position effect
Upstream conserved sequence
Variant surface glycoprotein
Variant-specific surface protein.
The writing of this review is in part supported by a grant from the National Science and Engineering Research Council of Canada (NSERC) (#217548-2010) to KY and an NSERC graduate studentship to DJ.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.